Chinese herbal medicine tianqi reduces progression from impaired glucose tolerance to diabetes: A double-blind, randomized, placebo-controlled, multicenter trial

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 2, 2014, Pages 648-655

  Lian, Fengmei ^a   Li, Guangwei ^b   Chen, Xinyan ^a   Wang, Xiuzhi ^c   Piao, Chunli ^d   Wang, Jingfei ^e   Hong, Yuzhi ^f   Ba, Zhuoma ^g   Wu, Shentao ^h   Zhou, Xiaoyan ⁱ   Lang, Jiangming ^j   Liu, Yajun ^k   Zhang, Rongfang ^l   Hao, Jianjun ⁱ   Zhu, Zhangzhi ^m   Li, H ⁿ   Liu, Hong Fang ^o   Cao, Aimei ^p   Yan, Z ^a   An, Y ^b   Bai, Yujing ^a   Wang, Qiang ⁱ   Zhen, Zhong ^a   Yu, Chunhao ^q   Wang, Chong Zhi ^q   Yuan, Chun Su ^q   Tong, Xiaolin ^a   more..

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b FUWAI HOSPITAL   (China)

^c Capital Medical University Pinggu Teaching Hospital   (China)

^d CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

^e Traditional Chinese Medicine Hospital of Mentougou District   (China)

^f Hangzhou Hospital of Traditional Chinese Medicine   (China)

^g Qinghai Provincial Hospital of Traditional Chinese Medicine   (China)

^h FIRST TEACHING HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

ⁱ Guangzhou Nansha District Hospital of Traditional Chinese Medicine   (China)

^j Foshan Hospital of Traditional Chinese Medicine   (China)

^k Beijing Huimin Hospital   (China)

^l Yangquan First People's Hospital   (China)

^m GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

ⁿ Shenzhen Hospital of Traditional Chinese Medicine   (China)

^o BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^p Beijing Changping Hospital of Traditional Chinese Medicine   (China)

^q UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; MIDDLE AGED; PREDIABETIC STATE; TREATMENT OUTCOME;

EID: 84893814398     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3276     Document Type: Article

References (31)

1. International Diabetes Federation. Diabetes atlas. http://www. idf.org/diabetesatlas/. Accessed August 15, 2013.
2. UnwinN, ShawJ, Zimmet P, Alberti KG.Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708-723.
3. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090-1101.
4. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783-1789.
5. Zhao Q, Guo B, Yang W. Tianqi capsule to treat type 2 diabetes: a trial of 300 cases. J Shandong Univ Tradit Chin Med. 2003;27:191-192.
6. Cai HQ, Ge HQ, Zhang XJ. Tianqi capsule to treat type 2 diabetes: a trial of 60 cases. J Jilin Univ. 2003;29:669-671.
7. Wu Y, Ou-Yang JP, Wu K, Wang Y, Zhou YF, Wen CY. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. Acta Pharmacol Sin. 2005;26:345-352.
8. Zou F, Mao XQ, Wang N, Liu J, Ou-Yang JP. Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation ofAMPK.Acta Pharmacol Sin. 2009; 30:1607-1615.
9. Tang LQ, Wei W, Chen LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol. 2006;108:109-115.
10. Wang C, Li J, Lv X, et al. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. Eur J Pharmacol. 2009;620:131-137.
11. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57:712-717.
12. Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes. 2002;51:1851-1858.
13. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2006;550:173-179.
14. Cho WC, Yip TT, Chung WS, et al. Altered expression of serum protein in ginsenoside Re-treated diabetic rats detected by SELDITOF MS. J Ethnopharmacol. 2006;108:272-279.
15. Sakai K, Matsumoto K, Nishikawa T, et al. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells. Biochem Biophys Res Commun. 2003;300:216-222.
16. Tong XL, Wu ST, Lian FM, et al. The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial. Diabetes Obes Metab. 2013;15:448-454.
17. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
18. Edeoga C, Dagogo-Jack S. Understanding and identifying pre-diabetes- can we halt the diabetes epidemic? Eur Endocrinol. 2008; 4:16-18.
19. DeFronzo RA, Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care. 2011; 34(suppl 2):S202-S209.
20. Li YR, Yang XN, Yang YS, Chen XY, Dong C. Observation of clinical therapeutic effects on 64 cases of impaired glucose tolerance in traditional medicine intervention. Chin J Exp TraditMedFormul. 2010;16:215-217.
21. Kanat M, Mari A, Norton L, et al. Distinctβ-cell defects in impaired fasting glucose and impaired glucose tolerance. Diabetes. 2012;61: 447-453.
22. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
23. Li G, Hu Y, Yang W, et al. Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study. Diabetes Res Clin Pract. 2002;58:193-200.
24. Kuriyan R, Rajendran R, Bantwal G, Kurpad AV. Effect of supplementation of Coccinia cordifolia extract on newly detected diabetic patients. Diabetes Care. 2008;31:216-220.
25. Tong XL, Dong L, Chen L, Zhen Z. Treatment of diabetes using traditional Chinese medicine: past, present and future. Am J Chin Med. 2012;40:877-886.
26. Huang W, Yu J, Jia X, Xiong L, Li N, Wen X. Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats. Am J Chin Med. 2012;40: 721-733.
27. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368:1096-1105.
28. DeFronzo RA, Tripathy D, Schwenke DC, et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364:1104-1115.
29. Chiasson JL, JosseRG,GomisR, HanefeldM,Karasik A, LaaksoM. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072-2077.
30. Tuomilehto J, Lindstrom J, Hellmich M, et al. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus- The STOP-NIDDM risk-score. Diabetes Res Clin Pract. 2010;87: 267-274.
31. Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005;28:888-894.